Literature DB >> 34186027

Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors.

Han Wang1, Shiyun Lv1, David Stroebel2, Jinbao Zhang3, Yijie Pan3, Xuejing Huang3, Xing Zhang4, Pierre Paoletti2, Shujia Zhu5.   

Abstract

N-methyl-D-aspartate (NMDA) receptors are glutamate-gated calcium-permeable ion channels that are widely implicated in synaptic transmission and plasticity. Here, we report a gallery of cryo-electron microscopy (cryo-EM) structures of the human GluN1-GluN2A NMDA receptor at an overall resolution of 4 Å in complex with distinct ligands or modulators. In the full-length context of GluN1-GluN2A receptors, we visualize the competitive antagonists bound to the ligand-binding domains (LBDs) of GluN1 and GluN2A subunits, respectively. We reveal that the binding of positive allosteric modulator shortens the distance between LBDs and the transmembrane domain (TMD), which further stretches the opening of the gate. In addition, we unexpectedly visualize the binding cavity of the "foot-in-the-door" blocker 9-aminoacridine within the LBD-TMD linker region, differing from the conventional "trapping" blocker binding site at the vestibule within the TMD. Our study provides molecular insights into the crosstalk between LBDs and TMD during channel activation, inhibition, and allosteric transition.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  9-aminoacrodine; NMDA receptor; allosteric modulation; gating transition

Mesh:

Substances:

Year:  2021        PMID: 34186027     DOI: 10.1016/j.neuron.2021.05.031

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   18.688


  6 in total

1.  In silico and in vivo neuropharmacological evaluation of two γ-amino acid isomers derived from 2,3-disubstituted benzofurans, as ligands of GluN1-GluN2A NMDA receptor.

Authors:  Arturo Coaviche-Yoval; José G Trujillo-Ferrara; Marvin A Soriano-Ursúa; Erik Andrade-Jorge; Luis A Sánchez-Labastida; Héctor Luna; Ricardo Tovar-Miranda
Journal:  Amino Acids       Date:  2021-12-02       Impact factor: 3.520

2.  A Breakthrough in Understanding the Rapid Antidepressant Effect of Ketamine Based on Structural Analysis.

Authors:  Hongmei Liu; Xiaohui Wu; Jun Chen; Yiru Fang
Journal:  Neurosci Bull       Date:  2021-11-16       Impact factor: 5.203

3.  Identification of a Subtype-Selective Allosteric Inhibitor of GluN1/GluN3 NMDA Receptors.

Authors:  Yue Zeng; Yueming Zheng; Tongtong Zhang; Fei Ye; Li Zhan; Zengwei Kou; Shujia Zhu; Zhaobing Gao
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

Review 4.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

5.  Paradigmatic De Novo GRIN1 Variants Recapitulate Pathophysiological Mechanisms Underlying GRIN1-Related Disorder Clinical Spectrum.

Authors:  Ana Santos-Gómez; Federico Miguez-Cabello; Natalia Juliá-Palacios; Deyanira García-Navas; Víctor Soto-Insuga; Juan J García-Peñas; Patricia Fuentes; Salvador Ibáñez-Micó; Laura Cuesta; Ramón Cancho; Patricia Andreo-Lillo; Gema Gutiérrez-Aguilar; Olga Alonso-Luengo; Ignacio Málaga; Antonio Hedrera-Fernández; Àngels García-Cazorla; David Soto; Mireia Olivella; Xavier Altafaj
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

6.  Development and characterization of functional antibodies targeting NMDA receptors.

Authors:  Nami Tajima; Noriko Simorowski; Remy A Yovanno; Michael C Regan; Kevin Michalski; Ricardo Gómez; Albert Y Lau; Hiro Furukawa
Journal:  Nat Commun       Date:  2022-02-17       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.